Tower Research Capital (TRC)’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-334
| Closed | -$106K | – | 6270 |
|
|
2023
Q4 | $106K | Sell |
334
-1,176
| -78% | -$372K | ﹤0.01% | 2611 |
|
|
2023
Q3 | $255K | Sell |
1,510
-561
| -27% | -$94.9K | 0.01% | 1282 |
|
|
2023
Q2 | $449K | Buy |
2,071
+131
| +7% | +$28.4K | 0.02% | 1043 |
|
|
2023
Q1 | $352K | Buy |
1,940
+668
| +53% | +$121K | 0.01% | 1042 |
|
|
2022
Q4 | $250K | Sell |
1,272
-6,755
| -84% | -$1.33M | 0.01% | 1158 |
|
|
2022
Q3 | $1.81M | Buy |
8,027
+5,018
| +167% | +$1.13M | 0.03% | 458 |
|
|
2022
Q2 | $381K | Buy |
3,009
+2,212
| +278% | +$280K | 0.01% | 1304 |
|
|
2022
Q1 | $101K | Sell |
797
-2,252
| -74% | -$285K | ﹤0.01% | 2192 |
|
|
2021
Q4 | $399K | Buy |
3,049
+1,530
| +101% | +$200K | 0.01% | 1270 |
|
|
2021
Q3 | $186K | Sell |
1,519
-1,323
| -47% | -$162K | ﹤0.01% | 1891 |
|
|
2021
Q2 | $324K | Buy |
2,842
+2,088
| +277% | +$238K | 0.01% | 1534 |
|
|
2021
Q1 | $91K | Sell |
754
-643
| -46% | -$77.6K | ﹤0.01% | 2662 |
|
|
2020
Q4 | $142K | Buy |
1,397
+527
| +61% | +$53.6K | ﹤0.01% | 2031 |
|
|
2020
Q3 | $67K | Sell |
870
-4,285
| -83% | -$330K | ﹤0.01% | 3420 |
|
|
2020
Q2 | $575K | Buy |
+5,155
| New | +$575K | 0.02% | 905 |
|